Q-Line Biotech Company Description
Q-Line Biotech Limited develops, manufactures, and markets various reagents and consumables in India and internationally.
It offers reagent kits, rapid cards, consumables, and point-of-care strips for applications in immunodiagnostics, hematology, molecular diagnostics, clinical chemistry, and others, as well as in vitro testing of human samples, supporting disease prediction, prevention, diagnosis, monitoring, and health status evaluation.
The company also provides diagnostic equipment comprising analyzers, point-of-care devices, and other critical components for diagnostic procedures; medical equipment maintenance services; and trades in macro cuvettes with balls, lab plastic plates, laboratory plastic tip rack, syringe pumps, and other consumables.
In addition, it offers Selectra Pro M, an automatic clinical chemistry analyzer. Further, the company develops Selectra Pro XL, an automatic clinical chemistry analyzer for large laboratories and hospital networks; Mircolab 300, a semi-automatic clinical chemistry analyzer for smaller facilities and point-of-care settings; Medonic M20, a three-part hematology analyzer prototype; KC1 Delta, a coagulation analyzer; InnoLyte electrolyte analyzer and an automated slide stainer; and Q-Count 5, a hematology analyzer.
It serves diagnostic service providers, diagnostic labs, hospitals, and medical colleges. The company also exports its products.
Q-Line Biotech Limited was incorporated in 2010 and is based in Lucknow, India.
| Country | India |
| Founded | 2010 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| Employees | 313 |
| CEO | Ajay Mahanty |
Contact Details
Address: Kanpur Road Lucknow, 226012 India | |
| Phone | 91 52 2243 5570 |
| Website | qlinebiotech.com |
Stock Details
| Ticker Symbol | QLINE |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Ajay Mahanty | Chief Executive Officer |
| Meenal Gupta | Chief Financial Officer |